Please login to the form below
Stamp Out Gout (Disease Awareness)
Want to know which agency did which ad? Search using one of the options below.
« Previous page
1
Next page »
« Previous page
1
Next page »
Featured jobs
-
Scientific Director
-
£60000 - £85000 per annum, Benefits: Bonus, pension, subsidised gym and much more
-
Account Manager
-
£Competitive Salary
-
Experienced medical editor
-
Competitive salary and bonus scheme
- Senior Medical Writer, MedComms Agency
-
Salary TBC
- Digital Associate Director - Medcomms
-
£65000 - £80000 per annum
-
Publications director
-
Competitive salary and bonus scheme
-
Account director
-
Competitive salary and bonus scheme
-
Account Manager (PR)
-
Great Benefits
-
Account Director, Medical Education
-
Salary TBC
- Account Director, Healthcare Communications
-
Salary TBC
-
Senior External Communications Lead
-
£Competitive Salary
- Brand Manager - Medium Global Pharma Company
-
£Competitive Financial Package
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- Senior Medical Writer or Lead Medical Writer
-
£Competitive Salary
-
Account Director
-
£Competitive Salary
- Group Director of Medical Affairs and Scientific Strategy, Medic...
-
Substantial six figure package
Subscribe to our email news alerts
- Novo Nordisk awakens its ‘Sleeping Beauty’
- Genital herpes vaccine candidate heads for human studies
- 20 for 2020 – Five pharma companies to watch
- FDA sets June decision date for Tecentriq monotherapy in NSCLC
- Bayer shares dip as Novartis gets EU okay for Beovu in wet AMD
- Novo Nordisk awakens its ‘Sleeping Beauty’
- Introducing Nucleus POLAR™, a state-of-the-art external expert search engine and engagement management tool
- GSK pays $50m upfront to tap Immatics’ cell therapy platform
- Researchers discover new antibiotic using AI
- Bedrock Group celebrates a trio of new hires
- Tocagen merges with Forte Biosciences after brain cancer fail
- Immutep spikes on trial of its LAG-3 drug with Keytruda
PMHub
Nobull Communications
Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...
Quick links
Infographics
